StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Earnings

Eton Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 18, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$57.90M
+157.3% on a year earlier
non-GAAP diluted EPS, Q3 FY2026
$0.50
$0.04 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Eton Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 18, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$57.90M+157.3%$1.06$0.50Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026after the close$37.60M+98.9%$0.35$0.43Release
Q1 FY2026ended Mar 31, 2026May 14, 2026after the close$24.30M+40.5%$0.05$0.14Release
Q4 FY2025ended Dec 31, 2025Mar 19, 2026after the close$21.30M+83.6%$0.05$0.19Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$22.50M+118.4%-$0.07$0.04Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$18.90M+107.7%-$0.10$0.03Release
Q1 FY2025ended Mar 31, 2025May 13, 2025after the close$17.30M+116.3%-$0.06$0.07Release
Q4 FY2024ended Dec 31, 2024Mar 18, 2025before the open$11.60M+58.9%-$0.02–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$10.30M+47.1%$0.02–Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$9.10M-24.2%-$0.11–Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close$8.00M+50.9%-$0.03–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Eton Pharmaceuticals's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueFY2026$175.00M–NewNov 5, 2026
revenueFY2026$145.00M$120.00MRaisedAug 13, 2026
adjusted gross marginnon-GAAPFY202670%–NewNov 5, 2026
adjusted gross marginnon-GAAPFY202670%70%ReaffirmedAug 13, 2026
Adjusted EBITDA marginnon-GAAPFY202635%30%RaisedAug 13, 2026
Adjusted EBITDA marginnon-GAAPFY202640%–NewNov 5, 2026
Adjusted EBITDA marginnon-GAAPFY202630%–NewMar 19, 2026

Guidance vs results

The last range Eton Pharmaceuticals gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2025Revenue$80.00M$22.50MBelow range

Guidance history

Every forecast Eton Pharmaceuticals put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDA marginFY202640%New
Nov 5, 2026adjusted gross marginFY202670%New
Nov 5, 2026revenueFY2026$175.00MNew
Aug 13, 2026adjusted gross marginFY202670%Reaffirmed
Aug 13, 2026Adjusted EBITDA marginFY202635%Raised
Aug 13, 2026R&D expensesfull year$10.00M – $14.00M–
Aug 13, 2026revenueFY2026$145.00MRaised
May 14, 2026adjusted gross marginFY202670%New
May 14, 2026Adjusted EBITDA marginFY202630%New
May 14, 2026revenuesFY2026$120.00MRaised
Mar 19, 2026Adjusted EBITDA marginFY202630%New
Mar 19, 2026revenuesFY2026$110.00MNew
Nov 6, 2025adjusted gross marginQ4 FY202570%New
Aug 7, 2025adjusted gross profitFY202570%Reaffirmed
Aug 7, 2025annual revenue run rateQ3 FY2025$80.00MNew
May 13, 2025adjusted gross profitFY202570%New
May 13, 2025annual revenue run rateFY2025$80.00MNew
May 9, 2024R&D spendFY2024$4.00MNew
Aug 10, 2023total revenueFY2023$30.00MNew
May 12, 2022revenueFY2022$25.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Eton Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. News
  5. Results
  6. News
  7. Results
  8. News
  9. News
  10. Update
  11. Results
  12. News
  13. News
  14. Update
  15. Results

See a number that looks wrong?